Journal
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY
Volume 6, Issue 3, Pages 100-101Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/cia2.12282
Keywords
-
Categories
Ask authors/readers for more resources
Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis, even if the skin eruptions are not fully resolved.
Dupilumab treatment reduced serum SCCA2 levels in patients with atopic dermatitis. Interestingly, even though the skin eruptions had not yet fully disappeared, serum SCCA2 levels were reduced well to below normal by the administration of dupilumab.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
